Researchers have announced a new hair loss study in relation to a potential treatment for the autoimmune condition, Alopecia Areata. A clinical trial due to start towards the end of November 2015 will explore whether Secukinumab (brand name: Cosentyx) – a drug which is currently FDA-approved for the treatment of another autoimmune condition, rheumatoid arthritis – could prove effective in […]

Read More